UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNA

Scientific reports, 2021-02, Vol.11 (1), p.3138-3138, Article 3138

2021

Volltextzugriff (PDF)

Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy

The journal of pathology. Clinical research, 2021-05, Vol.7 (3), p.209-219

2021

Volltextzugriff (PDF)

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, or in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer

British journal of cancer, 1996-10, Vol.74 (8), p.1286-1291

1996

Volltextzugriff (PDF)

Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Breast cancer research : BCR, 2006-01, Vol.8 (2), p.R13-R13, Article R13

2006

Volltextzugriff (PDF)

Randomized, Placebo-Controlled Trial of Clodronate in Patients With Primary Operable Breast Cancer

Journal of clinical oncology, 2002-08, Vol.20 (15), p.3219-3224

2002

Volltextzugriff (PDF)

Prognostic significance of TP53 alterations in breast carcinoma

British journal of cancer, 1993-09, Vol.68 (3), p.540-548

1993

Volltextzugriff (PDF)

The effect of pre-morbid height and weight on the survival of breast cancer patients

British journal of cancer, 1990-08, Vol.62 (2), p.299-303

1990

Volltextzugriff (PDF)

Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy

European journal of cancer (1990), 2005-03, Vol.41 (5), p.694-701

2005

Volltextzugriff (PDF)

Influence of Neoadjuvant Anastrozole (Arimidex) on Intratumoral Estrogen Levels and Proliferation Markers in Patients with Locally Advanced Breast Cancer

Clinical cancer research, 2001-05, Vol.7 (5), p.1230-1236

2001

Volltextzugriff (PDF)

Expression of EGFR Family and Steroid Hormone Receptors in Ductal Carcinoma in situ of the Breast

Ultrastructural pathology, 2001, Vol.25 (5), p.349-356

Suo, Asle Bjaamer, Lars Ottestad, Jahn M. Nesland, Zhenhe

2001

Volltextzugriff (PDF)

Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment

Journal of personalized medicine, 2023-01, Vol.13 (1), p.42

2023

Volltextzugriff (PDF)

Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis

British journal of cancer, 1990-10, Vol.62 (4), p.585-590

1990

Volltextzugriff (PDF)

Screening for germ line TP53 mutations in breast cancer patients

Cancer research (Chicago, Ill.), 1992-06, Vol.52 (11), p.3234-3236

1992

Volltextzugriff (PDF)

Changes in bone metabolism after 2 years’ treatment with exemestane (E) in postmenopausal women with early breast cancer (EBC) at low risk: Follow-up (FU) results of a randomized placebo-controlled study

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.531-531

2005

Volltextzugriff (PDF)

Estrogens and bone metabolism in postmenopausal women with early breast cancer at low risk treated with exemestane: a randomized placebo-controlled study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.531-531

2004

Volltextzugriff (PDF)

Effect of exemestane on bone: A randomized placebo controlled study in postmenopausal women with early breast cancer at low risk

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.518-518

2004

Volltextzugriff (PDF)

Lipid and coagulation profile in postmenopausal women with early breast cancer at low risk treated with exemestane: A randomized, placebo-controlled study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.650-650

2004

Volltextzugriff (PDF)

Lipid and coagulation profile in postmenopausal women with early breast cancer at low risk treated with exemestane: A randomized, placebo-controlled study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.650-650

2004

Volltextzugriff (PDF)

Estrogens and bone metabolism in postmenopausal women with early breast cancer at low risk treated with exemestane: a randomized placebo-controlled study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.531-531

2004

Volltextzugriff (PDF)

Effect of exemestane on bone: A randomized placebo controlled study in postmenopausal women with early breast cancer at low risk

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.518-518

2004

Volltextzugriff (PDF)

Drug Sensitivity Testing of Human Breast Cancer

Acta oncologica, 1990, Vol.29 (3), p.335-338

1990

Volltextzugriff (PDF)

Flow Cytometric DNA Analysis as Prognostic Factor in Human Breast Carcinoma

Pathology, research and practice, 1993-05, Vol.189 (4), p.405-410

1993

Volltextzugriff (PDF)

Loss of heterozygosity at 11q23.1 in breast carcinomas: Indication for involvement of a gene distal and close to ATM

Genes chromosomes & cancer, 1997-03, Vol.18 (3), p.175-180

1997

Volltextzugriff (PDF)

Colony forming ability of human breast carcinomas: lack of prognostic significance

British journal of cancer, 1989-08, Vol.60 (2), p.216-219

1989

Volltextzugriff (PDF)

Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas

Genes chromosomes & cancer, 1992-03, Vol.4 (2), p.113-121

1992

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(60)
Buchkapitel
(1)

Sprache

Englisch
(58)
Norwegisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNA

Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, or in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer

Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Randomized, Placebo-Controlled Trial of Clodronate in Patients With Primary Operable Breast Cancer

Prognostic significance of TP53 alterations in breast carcinoma

The effect of pre-morbid height and weight on the survival of breast cancer patients

Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy

Influence of Neoadjuvant Anastrozole (Arimidex) on Intratumoral Estrogen Levels and Proliferation Markers in Patients with Locally Advanced Breast Cancer

Expression of EGFR Family and Steroid Hormone Receptors in Ductal Carcinoma in situ of the Breast

Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment

Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis

Screening for germ line TP53 mutations in breast cancer patients

Changes in bone metabolism after 2 years’ treatment with exemestane (E) in postmenopausal women with early breast cancer (EBC) at low risk: Follow-up (FU) results of a randomized placebo-controlled study

Estrogens and bone metabolism in postmenopausal women with early breast cancer at low risk treated with exemestane: a randomized placebo-controlled study

Effect of exemestane on bone: A randomized placebo controlled study in postmenopausal women with early breast cancer at low risk

Lipid and coagulation profile in postmenopausal women with early breast cancer at low risk treated with exemestane: A randomized, placebo-controlled study

Lipid and coagulation profile in postmenopausal women with early breast cancer at low risk treated with exemestane: A randomized, placebo-controlled study

Estrogens and bone metabolism in postmenopausal women with early breast cancer at low risk treated with exemestane: a randomized placebo-controlled study

Effect of exemestane on bone: A randomized placebo controlled study in postmenopausal women with early breast cancer at low risk

Drug Sensitivity Testing of Human Breast Cancer

Flow Cytometric DNA Analysis as Prognostic Factor in Human Breast Carcinoma

Loss of heterozygosity at 11q23.1 in breast carcinomas: Indication for involvement of a gene distal and close to ATM

Colony forming ability of human breast carcinomas: lack of prognostic significance

Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas

Suchergebnisse filtern